Inactive Instrument

News Opexa Therapeutics Inc Nasdaq

Equities

US68372T3014

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Acer Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Chris Schelling Ceases to Be Chief Executive Officer of Acer Therapeutics Inc	Nov. 20	CI
Harry S. Palmin Ceases to Be Chief Financial Officer of Acer Therapeutics Inc	Nov. 20	CI
Acer Therapeutics Inc. Announces Executive Changes	Nov. 20	CI
Zevra Therapeutics Completes Acer Acquisition	Nov. 20	MT
Zevra Therapeutics, Inc. completed the acquisition of Acer Therapeutics Inc. from funds affiliated with TVM Capital Life Science and others.	Nov. 16	CI
Acer Therapeutics Inc.(OTCPK:ACER) dropped from S&P TMI Index	Nov. 13	CI
Transcript : Acer Therapeutics Inc. - Shareholder/Analyst Call	Nov. 08
Acer Therapeutics Inc.(OTCPK:ACER) dropped from NASDAQ Composite Index	Nov. 08	CI
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals	Nov. 02	AQ
ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER	23-10-10	BU
North American Morning Briefing : Inflation -2-	23-09-06	DJ
ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER	23-09-05	BU
HC Wainwright Downgrades Acer Therapeutics to Neutral From Buy	23-09-05	MT
North American Morning Briefing : Chinese Data -2-	23-09-05	DJ
Top Midday Decliners	23-09-01	MT
Roth MKM Downgrades Acer Therapeutics to Neutral From Buy, Price Target is $1.50	23-09-01	MT
Sector Update: Health Care Stocks Lower in Late Afternoon Trading	23-08-31	MT
Sector Update: Health Care	23-08-31	MT
Top Midday Gainers	23-08-31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Opexa Therapeutics Inc Nasdaq

Equities

US68372T3014

Summary

Filters